5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.35▼ | 6.43▼ | 6.43▼ | 5.53▲ | 3.92▲ |
MA10 | 6.40▼ | 6.35▼ | 6.38▼ | 4.93▲ | 2.14▲ |
MA20 | 6.46▼ | 6.42▼ | 6.14▲ | 4.47▲ | 1.27▲ |
MA50 | 6.44▼ | 5.42▲ | 5.04▲ | 2.02▲ | 1.35▲ |
MA100 | 6.28▲ | 4.95▲ | 4.22▲ | 1.21▲ | 1.95▲ |
MA200 | 5.41▲ | 3.00▲ | 2.30▲ | 1.15▲ | 4.27▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.020▼ | -0.076▼ | -0.053▼ | 0.126▲ | 0.650▲ |
RSI | 42.430▼ | 54.465▲ | 59.484▲ | 78.033▲ | 86.997▲ |
STOCH | 17.857▼ | 70.934 | 74.486 | 47.230 | 73.096 |
WILL %R | -100.000▼ | -43.529 | -51.020 | -22.074▲ | -9.925▲ |
CCI | -100.292▼ | -27.110 | -56.607 | 162.623▲ | 167.334▲ |
▼ GAP | $GBIO Open Gap Down %2 | Set Alert |
Wednesday, August 13, 2025 07:49 AM
Generation Bio (GBIO) soars 45% after announcing a strategic review exploring mergers, acquisitions, or sales.
|
Tuesday, August 12, 2025 01:05 PM
New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of ...
|
Monday, July 07, 2025 06:05 AM
CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 6.49 | 6.65 | 6.28 | 6.29 | 188,854 |
14/08/25 | 6.45 | 6.68 | 5.75 | 6.66 | 765,446 |
13/08/25 | 5.22 | 6.95 | 5.15 | 6.61 | 10,031,001 |
12/08/25 | 4.09 | 4.27 | 3.97 | 4.05 | 3,462,915 |
11/08/25 | 4.11 | 4.34 | 3.96 | 4.04 | 125,810 |
08/08/25 | 4.14 | 4.546 | 4.04 | 4.10 | 58,548 |
07/08/25 | 4.28 | 4.2935 | 4.14 | 4.15 | 53,320 |
06/08/25 | 4.57 | 4.57 | 4.28 | 4.28 | 27,858 |
05/08/25 | 4.62 | 4.8295 | 4.4911 | 4.56 | 56,014 |
04/08/25 | 4.33 | 4.63 | 4.2511 | 4.58 | 106,556 |
|
|
||||
|
|
||||
|
|